- Home
- MDGL vs KD Comparison
MDGL vs KD Comparison
Compare MDGL & KD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- KD
- Stock Information
- Founded
- MDGL 2011
- KD 2020
- Country
- MDGL United States
- KD United States
- Employees
- MDGL N/A
- KD N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- KD EDP Services
- Sector
- MDGL Health Care
- KD Technology
- Exchange
- MDGL Nasdaq
- KD Nasdaq
- Market Cap
- MDGL 9.6B
- KD 7.3B
- IPO Year
- MDGL N/A
- KD N/A
- Fundamental
- Price
- MDGL $420.19
- KD $28.60
- Analyst Decision
- MDGL Strong Buy
- KD Buy
- Analyst Count
- MDGL 12
- KD 4
- Target Price
- MDGL $521.09
- KD $42.00
- AVG Volume (30 Days)
- MDGL 270.5K
- KD 1.8M
- Earning Date
- MDGL 11-04-2025
- KD 11-04-2025
- Dividend Yield
- MDGL N/A
- KD N/A
- EPS Growth
- MDGL N/A
- KD N/A
- EPS
- MDGL N/A
- KD 1.23
- Revenue
- MDGL $515,547,000.00
- KD $15,061,000,000.00
- Revenue This Year
- MDGL $394.38
- KD $6.80
- Revenue Next Year
- MDGL $64.73
- KD $2.41
- P/E Ratio
- MDGL N/A
- KD $23.23
- Revenue Growth
- MDGL 3421.98
- KD N/A
- 52 Week Low
- MDGL $201.22
- KD $22.68
- 52 Week High
- MDGL $463.63
- KD $44.20
- Technical
- Relative Strength Index (RSI)
- MDGL 44.64
- KD 42.01
- Support Level
- MDGL $413.82
- KD $28.01
- Resistance Level
- MDGL $445.06
- KD $28.82
- Average True Range (ATR)
- MDGL 16.35
- KD 0.82
- MACD
- MDGL -3.80
- KD 0.09
- Stochastic Oscillator
- MDGL 17.11
- KD 36.60
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About KD Kyndryl Holdings Inc.
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.